Daclizumab Shows Promise in Multiple Sclerosis Trial – Internal Medicine News Digital Network
Daclizumab Shows Promise in Multiple Sclerosis TrialInternal Medicine News Digital NetworkAMSTERDAM – Daclizumab reduced the rate of relapse and the rate of disability progression in patients with relapsing-remitting multiple sclerosis in a 1-year, p…